Nanofibrous biomimetic mesh can be used for pelvic reconstructive surgery: A randomized study. (August 2016)

• Record Type: Journal Article
• Authors: Ding, Jing; Deng, Mou; Song, Xiao-chen; Chen, Chun; Lai, Kui-lin; Wang, Guo-shuai; Yuan, Yu-yu; Xu, Tao; Zhu, Lan
• Is Part Of: Journal of the mechanical behavior of biomedical materials. Volume 61(2016)
• Page Start: 26
• Page End: 35
• Publication Date: 2016-08
• Subjects: Pelvic reconstructive surgery -- Nanofibrous biomimetic mesh -- Gynemesh™PS -- Polyvinylidene fluoride -- Polypropylene; Biomedical materials -- Periodicals; Biomedical materials -- Mechanical properties -- Periodicals; Biomedical materials; Biomedical materials -- Mechanical properties; Periodicals; Electronic journals; 610.28
• DOI: 10.1016/j.jmbbm.2016.01.003
• Languages: English
• ISSNs: 1751-6161

Abstract

Abstract: Background: Implantation of nonabsorbable polypropylene (PP) mesh in the vagina is the main surgical treatment for pelvic organ prolapse (POP); however, clinical outcomes remain controversial and far from satisfactory. In particular, reducing the exposure or erosion of vaginal implants to obtain improved functional reconstruction is challenging. There is an urgent need for the development of new materials and/or products for POP treatment. A nanofibrous biomimetic mesh was recently developed to address this issue. Objective: In this study, the basic properties of the newly developed mesh, including structural characteristics, mechanical properties, biological response of human umbilical cord mesenchymal stem cells in vitro, and tissue regeneration and biocompatibility in vivo, were evaluated and compared with those of Gynemesh™PS. Methods: Scanning electron microscopy and uniaxial tensile methods were used to evaluate microstructure and mechanical properties, respectively. Mesenchymal stem cell growth on the meshes was observed by fluorescence microscopy to visualize the expression of enhanced red fluorescent protein. Twenty-four mature female Sprague Dawley rats were randomly assigned to two groups: group 1 (nanofibrous biomimetic mesh, Medprin, Germany, n =12) and group 2 (Gynemesh TM PS, Ethicon, USA; n =12). The posterior vaginal wall was incised from the introitus, and the mesh was then implanted. Three implants of each type were tested for 1, 4, 8 and 12 weeks. Connective tissue organization, inflammation, vascularization, and regenerated tissue were histologically assessed. Results: The nanofibrous biomimetic mesh is a relatively heavy material and exhibited lower porosity than Gynemesh TM PS. The new mesh was stiffer than Gynemesh TM PS ( p <0.001) but supported human umbilical cord mesenchymal stem cell attachment. Erosion of the grafts did not occur in any animal. The nanofibrous biomimetic mesh was encapsulated by a thicker layer of connective tissue and was associated with significantly greater inflammatory scores compared with Gynemesh TM PS. At 12 weeks, the vascularization of the new mesh was greater than that of Gynemesh TM PS ( p <0.05). No significant difference in the thickness of the smooth muscle layer following implantation was observed between the two groups ( p >0.05). Conclusions: The nanofibrous biomimetic mesh is a candidate for reinforcing pelvic reconstruction. The mesh could be improved by decreasing its weight and stiffness and increasing its porosity. This mesh could serve as a carrier for stem cells in future regenerative medicine and tissue engineering research.